Tissue engineering and regenerative medicine
2024 Activity indicator
- 1 public competitive project led: ISCIII
- 5 private projects led
- 2 clinical studies led
- 3 competitive HR contracts
- 47 publications
- IF: 184.90
- Q1 publications: 26 (55%)
- D1 publications: 5 (11%)
- 11 thesis
- 1 recognition to a member of the group
- Evaluators in international public agencies: 2 researchers
- Evaluators in national public agencies: 3 researchers
- Member of editorial committees: 2 researchers
Milestones
- European patent application (EP23382390.5) 'Method for monitoring the spatial deviation with respect to a planned surgical procedure' with PCT/EP2024/061573.
- Consolidation of the MITIC-CM Consortium of the Biomedicine R&D Activities Programme of the Community of Madrid (B2022/BMD-7321).
- A total of 11 doctoral theses supervised, which reaffirms the group's commitment, impact and influence on training and academic development. This effort has been recognised with a prestigious award for excellence in the supervision of doctoral theses.
- Participation and leadership in the MADRIDNIGHT Programme 'Researchers and citizens: facing together the European challenges'.
- High impact results of the public project PI21/01244 with the publication Muñoz-Chápuli Gutiérrez M, Prat AS, Vila AD, Claverol MB, Martínez PP, Recarte PP, Benéitez MV, García CA, Muñoz EC, Navarro M, Navarro PG, Álvarez-Mon M, Ortega MA, de León-Luís J. Post-COVID-19 condition in pregnant and postpartum women: a long-term follow-up, observational prospective study. EClinicalMedicine. 2024 5;67:102398. doi: 10.1016/j.eclinm.2023.102398.
Bibliometrics
|
|
|
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 24 | 66.94 | 3.04 | 14 | 58 | 0 | 0 | |||||||
| 2021 | 52 | 212.05 | 4.16 | 44 | 85 | 3 | 6 | |||||||
| 2022 | 53 | 243.54 | 4.60 | 45 | 85 | 2 | 4 | |||||||
| 2023 | 55 | 277.97 | 4.60 | 44 | 80 | 10 | 18 | |||||||
| 2024 | 47 | 184.90 | 4.20 | 42 | 89 | 5 | 11 | |||||||
| 231 | 985.40 | 4.12 | 189 | 82 | 20 | 9 |
* Only original articles, editorial material, guidelines and reviews.
